SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
57 hedge funds and large institutions have $37.8M invested in Syros Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 9 closing their positions.
Holders
57
Holders Change
+4
Holders Change %
+7.55%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
12
Reduced
14
Closed
9
Calls
$1.08M
Puts
$22K
Net Calls
+$1.06M
Net Calls Change
-$829K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
US Bancorp
Minneapolis,
Minnesota
| $144 | – | – | – |
|
|
HWMA
52
Heritage Wealth Management (Arizona)
Phoenix,
Arizona
| $129 | +$64 | +18 | +100% |
|
53
Dimensional Fund Advisors
Austin,
Texas
| $109 | +$3 | +702 | +2% |
|
54
Fidelity Investments
Boston,
Massachusetts
| $43 | -$903K | -252,017 | -100% |
|
|
PFO
55
Pathstone Family Office
Englewood,
New Jersey
| – | -$282K | -43,826 | Closed |
|
56
Walleye Capital
New York
| – | -$82K | -12,800 | Closed |
|
|
ACM
57
Aquatic Capital Management
Chicago,
Illinois
| – | -$5K | -800 | Closed |
|
58
BNP Paribas Financial Markets
Paris,
France
| – | -$3.23K | -502 | Closed |
|
59
Citigroup
New York
| – | -$1K | -111 | Closed |
|